-
Purposeexpresses Dendra2-Rpb1 fusion in mammalian cells. Possible to insert into the genome using the Piggibac system
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 81228 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepb53
-
Backbone manufacturerSystem Biosciences
- Total vector size (bp) 13708
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameDendra2 - Rpb1 (alpha amanitin resistant)
-
Alt nameRPOLR2A, pIILS, POLRA, hsRPB1, POLR2, RPB1, RPBh1, RPOL2, RPO2, hRPB220
-
SpeciesH. sapiens (human)
-
Insert Size (bp)6698
-
MutationN792D alpha amanitin resistance mutation (Bartolomei & Corden Mol Gen Genet 1995)
-
Entrez GenePOLR2A (a.k.a. NEDHIB, POLR2, POLRA, RPB1, RPBh1, RPO2, RPOL2, RpIILS, hRPB220, hsRPB1)
- Promoter EF1a
-
Tag
/ Fusion Protein
- Dendra2 (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site AgeI (unknown if destroyed)
- 3′ cloning site Unknown (unknown if destroyed)
- 5′ sequencing primer M13_pUC_rev_primer
- 3′ sequencing primer M13_pUC_fwd_primer (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
PB53x EF1-Dendra2-RPB1Amr was a gift from Timothée Lionnet (Addgene plasmid # 81228 ; http://n2t.net/addgene:81228 ; RRID:Addgene_81228) -
For your References section:
RNA Polymerase II cluster dynamics predict mRNA output in living cells. Cho WK, Jayanth N, English BP, Inoue T, Andrews JO, Conway W, Grimm JB, Spille JH, Lavis LD, Lionnet T, Cisse II. Elife. 2016 May 3;5. pii: e13617. doi: 10.7554/eLife.13617. 10.7554/eLife.13617 PubMed 27138339